Variant report
Variant | nsv512026 |
---|---|
Chromosome Location | chr8:4941175-4944233 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187017934 | chr8:4941181-4941182 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192832977 | chr8:4941201-4941202 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184409671 | chr8:4941217-4941218 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs35524159 | chr8:4941226-4941227 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189341634 | chr8:4941233-4941234 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372848989 | chr8:4941235-4941236 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575958599 | chr8:4941236-4941237 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543360272 | chr8:4941237-4941238 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561916402 | chr8:4941238-4941239 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573978959 | chr8:4941239-4941240 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182223847 | chr8:4941242-4941243 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542457452 | chr8:4941295-4941296 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541265938 | chr8:4941313-4941314 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559569100 | chr8:4941390-4941391 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527808085 | chr8:4941393-4941394 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11781650 | chr8:4941437-4941438 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113879976 | chr8:4941489-4941490 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs202048580 | chr8:4941520-4941521 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564335060 | chr8:4941527-4941528 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531687168 | chr8:4941545-4941546 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184859846 | chr8:4941550-4941551 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568456764 | chr8:4941603-4941604 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562360259 | chr8:4941606-4941607 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189235254 | chr8:4941620-4941621 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11786658 | chr8:4941633-4941634 | Enhancers Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs374640027 | chr8:4941655-4941656 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539175328 | chr8:4941659-4941660 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557792825 | chr8:4941662-4941663 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs74592989 | chr8:4941682-4941683 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs17063304 | chr8:4941692-4941693 | Enhancers Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs1993284 | chr8:4941703-4941704 | Enhancers Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs181592703 | chr8:4941724-4941725 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185910626 | chr8:4941725-4941726 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs189631324 | chr8:4941735-4941736 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181163531 | chr8:4941741-4941742 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186050340 | chr8:4941753-4941754 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs77954722 | chr8:4941764-4941765 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545986662 | chr8:4941772-4941773 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564651414 | chr8:4941774-4941775 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371236729 | chr8:4941790-4941791 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148957539 | chr8:4941796-4941797 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145400056 | chr8:4941816-4941817 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs147620604 | chr8:4941817-4941818 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190956536 | chr8:4941832-4941833 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114316510 | chr8:4941833-4941834 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533521535 | chr8:4941837-4941838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551678506 | chr8:4941844-4941845 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs142133212 | chr8:4941863-4941864 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs145925333 | chr8:4941869-4941870 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs184056018 | chr8:4941886-4941887 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4939800-4941200 | Active TSS | Brain Inferior Temporal Lobe | brain |
2 | chr8:4940400-4941200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
3 | chr8:4940400-4941200 | Active TSS | Brain Hippocampus Middle | brain |
4 | chr8:4940600-4941200 | Active TSS | Brain Cingulate Gyrus | brain |
5 | chr8:4940800-4941800 | Active TSS | Brain Substantia Nigra | brain |
6 | chr8:4940800-4942400 | Enhancers | Primary hematopoietic stem cells | blood |
7 | chr8:4941000-4943800 | Weak transcription | Brain Angular Gyrus | brain |
8 | chr8:4941600-4941800 | Enhancers | Brain Anterior Caudate | brain |
9 | chr8:4941800-4942000 | Enhancers | Brain Substantia Nigra | brain |
10 | chr8:4942200-4942600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |